These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 36681816)
61. Inhibition of the platelet P2Y12 receptor for adenosine diphosphate does not impair the capacity of platelet to synthesize thromboxane A2. Scavone M; Femia EA; Caroppo V; Cattaneo M Eur Heart J; 2016 Nov; 37(44):3347-3356. PubMed ID: 26516174 [TBL] [Abstract][Full Text] [Related]
62. Inhibitory Effects of P2Y12 Receptor Antagonist on PAR1- and PAR4-AP-Induced Platelet Aggregation in Patients with Stroke or TIA. Kamada A; Shimizu M; Oura K; Yoshida M; Tsuda K; Oi K; Ishigaku Y; Natori T; Narumi S; Itabashi R; Maeda T; Terayama Y J Stroke Cerebrovasc Dis; 2021 Mar; 30(3):105547. PubMed ID: 33360254 [TBL] [Abstract][Full Text] [Related]
63. Platelet aggregation in response to ADP is highly variable in normal donors and patients on anti-platelet medication. Dunne E; Egan K; McFadden S; Foley D; Kenny D Clin Chem Lab Med; 2016 Jul; 54(7):1269-73. PubMed ID: 26562035 [TBL] [Abstract][Full Text] [Related]
64. The role of ADP receptors in platelet function. Murugappa S; Kunapuli SP Front Biosci; 2006 May; 11():1977-86. PubMed ID: 16368572 [TBL] [Abstract][Full Text] [Related]
65. Selective blockade of P2Y12 receptors by prasugrel inhibits myocardial infarction induced by thrombotic coronary artery occlusion in rats. Sugidachi A; Yamaguchi S; Jakubowski JA; Ohno K; Tomizawa A; Hashimoto M; Niitsu Y J Cardiovasc Pharmacol; 2011 Sep; 58(3):329-34. PubMed ID: 21697729 [TBL] [Abstract][Full Text] [Related]
66. The Gi-coupled P2Y12 receptor regulates diacylglycerol-mediated signaling in human platelets. Guidetti GF; Lova P; Bernardi B; Campus F; Baldanzi G; Graziani A; Balduini C; Torti M J Biol Chem; 2008 Oct; 283(43):28795-805. PubMed ID: 18755689 [TBL] [Abstract][Full Text] [Related]
68. The Ratio of ADP- to TRAP-Induced Platelet Aggregation Quantifies P2Y12-Dependent Platelet Inhibition Independently of the Platelet Count. Olivier CB; Meyer M; Bauer H; Schnabel K; Weik P; Zhou Q; Bode C; Moser M; Diehl P PLoS One; 2016; 11(2):e0149053. PubMed ID: 26885820 [TBL] [Abstract][Full Text] [Related]
69. α2A-Adrenergic receptor polymorphism potentiates platelet reactivity in patients with stable coronary artery disease carrying the cytochrome P450 2C19*2 genetic variant. Peace AJ; Mangiacapra F; Bailleul E; Delrue L; Dierickx K; Conte M; Puymirat E; Fraeymans AL; Meeus P; Bartunek J; Volpe M; Barbato E Arterioscler Thromb Vasc Biol; 2014 Jun; 34(6):1314-9. PubMed ID: 24723553 [TBL] [Abstract][Full Text] [Related]
70. Validation of a P2Y Amann M; Ferenc M; Valina CM; Bömicke T; Stratz C; Leggewie S; Trenk D; Neumann FJ; Hochholzer W Platelets; 2016 Nov; 27(7):668-672. PubMed ID: 27065056 [TBL] [Abstract][Full Text] [Related]
71. Role of P2Y1 purinoceptor in ADP-induced platelet activation. Savi P; Beauverger P; Labouret C; Delfaud M; Salel V; Kaghad M; Herbert JM FEBS Lett; 1998 Feb; 422(3):291-5. PubMed ID: 9498802 [TBL] [Abstract][Full Text] [Related]
72. GRK2 regulates ADP signaling in platelets via P2Y1 and P2Y12. Zhao X; Cooper M; Michael JV; Yarman Y; Baltz A; Chuprun JK; Koch WJ; McKenzie SE; Tomaiuolo M; Stalker TJ; Zhu L; Ma P Blood Adv; 2022 Aug; 6(15):4524-4536. PubMed ID: 35793439 [TBL] [Abstract][Full Text] [Related]
73. New highly active antiplatelet agents with dual specificity for platelet P2Y1 and P2Y12 adenosine diphosphate receptors. Yanachkov IB; Chang H; Yanachkova MI; Dix EJ; Berny-Lang MA; Gremmel T; Michelson AD; Wright GE; Frelinger AL Eur J Med Chem; 2016 Jan; 107():204-18. PubMed ID: 26588064 [TBL] [Abstract][Full Text] [Related]
74. Platelet receptor Gene (P2Y12, P2Y1) and platelet glycoprotein Gene (GPIIIa) polymorphisms are associated with antiplatelet drug responsiveness and clinical outcomes after acute minor ischemic stroke. Yi X; Zhou Q; Wang C; Lin J; Liu P; Fu C Eur J Clin Pharmacol; 2017 Apr; 73(4):437-443. PubMed ID: 28091702 [TBL] [Abstract][Full Text] [Related]
75. 1, 6-di-O-caffeoyl-β-D-glucopyranoside, a natural compound from Callicarpa nudiflora Hook impairs P2Y Fu J; Zhu X; Wang W; Lu H; Zhang Z; Liu T; Xu H; Fu H; Ma S; Luo Y Phytomedicine; 2017 Dec; 36():273-282. PubMed ID: 29157825 [TBL] [Abstract][Full Text] [Related]
79. In-vitro antiplatelet effect of melatonin in healthy individuals and patients with type 2 diabetes mellitus. Böhm A; Lauko V; Dostalova K; Balanova I; Varga I; Bezak B; Jajcay N; Moravcik R; Lazurova L; Slezak P; Mojto V; Kollarova M; Petrikova K; Danova K; Zeman M J Endocrinol Invest; 2023 Dec; 46(12):2493-2500. PubMed ID: 37148530 [TBL] [Abstract][Full Text] [Related]
80. ADP-Mediated Upregulation of Expression of CD62P on Human Platelets Is Critically Dependent on Co-Activation of P2Y1 and P2Y12 Receptors. Anderson R; Theron AJ; Steel HC; Nel JG; Tintinger GR Pharmaceuticals (Basel); 2020 Nov; 13(12):. PubMed ID: 33255391 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]